Human T-lymphotropic Virus 2: Clinical Trials

3 trials for Human T-lymphotropic Virus 2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Human T-lymphotropic Virus 2: new trials by email Literature Review of Human T-lymphotropic Virus 2 trials Research Report on Human T-lymphotropic Virus 2

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study
MP Diagnostics HTLV Blot 2.4 - HTLV-I Infections, HTLV-II Infections
Phase 4CompletedMP Biomedicals, LLC1502018-01-152018-09-13
Dual Algorithm Post Market Clinical Study
MP Diagnostics HTLV Blot 2.4 - HTLV-I Infections, HTLV-II Infections
CompletedMP Biomedicals, LLC1002017-03-012017-06-12
Evaluation of the MP Diagnostics HTLV Blot 2.4
CDPHL Algorithm - HTLV-I Infections, HTLV-II Infections
UnknownMP Biomedicals, LLC6002011-11-012011-11-08

Narrower conditions

HTLV-I Infections (3)  ·  HTLV-II Infections (3)  ·  Leukemia-Lymphoma, Adult T-Cell (3)  ·  Paraparesis, Tropical Spastic (3)

Broader conditions

Central Nervous System Diseases (3)  ·  Central Nervous System Infections (3)  ·  Deltaretrovirus Infections (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunologic Deficiency Syndromes (3)  ·  Immunoproliferative Disorders (3)  ·  Infections (3)  ·  Leukemia (3)  ·  Leukemia, Lymphoid (3)  ·  Leukemia, T-Cell (3)  ·  Lymphatic Diseases (3)  ·  Lymphoproliferative Disorders (3)  ·  Myelitis (3)

Sponsors

MP Biomedicals, LLC (3)

Countries

United States (3)

Top investigators

Susan Stramer, Ph.D (2)  ·  Sara Dionne, PhD (1)